Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis

Masahiro Gotoh, Hitoshi Ichikawa, Eri Arai, Suenori Chiku, Hiromi Sakamoto, Hiroyuki Fujimoto, Masaki Hiramoto, Takao Nammo, Kazuki Yasuda, Teruhiko Yoshida, Yae Kanai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of this study was to clarify the participation of expression of chimeric transcripts in renal carcinogenesis. Whole transcriptome analysis (RNA sequencing) and exploration of candidate chimeric transcripts using the deFuse program were performed on 68 specimens of cancerous tissue (T) and 11 specimens of non-cancerous renal cortex tissue (N) obtained from 68 patients with clear cell renal cell carcinomas (RCCs) in an initial cohort. As positive controls, two RCCs associated with Xp11.2 translocation were analyzed. After verification by reverse transcription (RT)-PCR and Sanger sequencing, 26 novel chimeric transcripts were identified in 17 (25%) of the 68 clear cell RCCs. Genomic breakpoints were determined in five of the chimeric transcripts. Quantitative RT-PCR analysis revealed that the mRNA expression levels for the MMACHC, PTER, EPC2, ATXN7, FHIT, KIFAP3, CPEB1, MINPP1, TEX264, FAM107A, UPF3A, CDC16, MCCC1, CPSF3, and ASAP2 genes, being partner genes involved in the chimeric transcripts in the initial cohort, were significantly reduced in 26 T samples relative to the corresponding 26 N samples in the second cohort. Moreover, the mRNA expression levels for the above partner genes in T samples were significantly correlated with tumor aggressiveness and poorer patient outcome, indicating that reduced expression of these genes may participate in malignant progression of RCCs. As is the case when their levels of expression are reduced, these partner genes also may not fully function when involved in chimeric transcripts. These data suggest that generation of chimeric transcripts may participate in renal carcinogenesis by inducing dysfunction of tumor-related genes.

Original languageEnglish
Pages (from-to)1018-1032
Number of pages15
JournalGenes Chromosomes and Cancer
Volume53
Issue number12
DOIs
Publication statusPublished - 2014 Dec 1
Externally publishedYes

Fingerprint

Gene Expression Profiling
Renal Cell Carcinoma
Genes
Kidney
Reverse Transcription
Carcinogenesis
RNA Sequence Analysis
Polymerase Chain Reaction
Messenger RNA
Neoplasms
Gene Expression

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis. / Gotoh, Masahiro; Ichikawa, Hitoshi; Arai, Eri; Chiku, Suenori; Sakamoto, Hiromi; Fujimoto, Hiroyuki; Hiramoto, Masaki; Nammo, Takao; Yasuda, Kazuki; Yoshida, Teruhiko; Kanai, Yae.

In: Genes Chromosomes and Cancer, Vol. 53, No. 12, 01.12.2014, p. 1018-1032.

Research output: Contribution to journalArticle

Gotoh, M, Ichikawa, H, Arai, E, Chiku, S, Sakamoto, H, Fujimoto, H, Hiramoto, M, Nammo, T, Yasuda, K, Yoshida, T & Kanai, Y 2014, 'Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis', Genes Chromosomes and Cancer, vol. 53, no. 12, pp. 1018-1032. https://doi.org/10.1002/gcc.22211
Gotoh, Masahiro ; Ichikawa, Hitoshi ; Arai, Eri ; Chiku, Suenori ; Sakamoto, Hiromi ; Fujimoto, Hiroyuki ; Hiramoto, Masaki ; Nammo, Takao ; Yasuda, Kazuki ; Yoshida, Teruhiko ; Kanai, Yae. / Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis. In: Genes Chromosomes and Cancer. 2014 ; Vol. 53, No. 12. pp. 1018-1032.
@article{67aad4a96bfe4989a24e86d06ca16fff,
title = "Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis",
abstract = "The aim of this study was to clarify the participation of expression of chimeric transcripts in renal carcinogenesis. Whole transcriptome analysis (RNA sequencing) and exploration of candidate chimeric transcripts using the deFuse program were performed on 68 specimens of cancerous tissue (T) and 11 specimens of non-cancerous renal cortex tissue (N) obtained from 68 patients with clear cell renal cell carcinomas (RCCs) in an initial cohort. As positive controls, two RCCs associated with Xp11.2 translocation were analyzed. After verification by reverse transcription (RT)-PCR and Sanger sequencing, 26 novel chimeric transcripts were identified in 17 (25{\%}) of the 68 clear cell RCCs. Genomic breakpoints were determined in five of the chimeric transcripts. Quantitative RT-PCR analysis revealed that the mRNA expression levels for the MMACHC, PTER, EPC2, ATXN7, FHIT, KIFAP3, CPEB1, MINPP1, TEX264, FAM107A, UPF3A, CDC16, MCCC1, CPSF3, and ASAP2 genes, being partner genes involved in the chimeric transcripts in the initial cohort, were significantly reduced in 26 T samples relative to the corresponding 26 N samples in the second cohort. Moreover, the mRNA expression levels for the above partner genes in T samples were significantly correlated with tumor aggressiveness and poorer patient outcome, indicating that reduced expression of these genes may participate in malignant progression of RCCs. As is the case when their levels of expression are reduced, these partner genes also may not fully function when involved in chimeric transcripts. These data suggest that generation of chimeric transcripts may participate in renal carcinogenesis by inducing dysfunction of tumor-related genes.",
author = "Masahiro Gotoh and Hitoshi Ichikawa and Eri Arai and Suenori Chiku and Hiromi Sakamoto and Hiroyuki Fujimoto and Masaki Hiramoto and Takao Nammo and Kazuki Yasuda and Teruhiko Yoshida and Yae Kanai",
year = "2014",
month = "12",
day = "1",
doi = "10.1002/gcc.22211",
language = "English",
volume = "53",
pages = "1018--1032",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis

AU - Gotoh, Masahiro

AU - Ichikawa, Hitoshi

AU - Arai, Eri

AU - Chiku, Suenori

AU - Sakamoto, Hiromi

AU - Fujimoto, Hiroyuki

AU - Hiramoto, Masaki

AU - Nammo, Takao

AU - Yasuda, Kazuki

AU - Yoshida, Teruhiko

AU - Kanai, Yae

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The aim of this study was to clarify the participation of expression of chimeric transcripts in renal carcinogenesis. Whole transcriptome analysis (RNA sequencing) and exploration of candidate chimeric transcripts using the deFuse program were performed on 68 specimens of cancerous tissue (T) and 11 specimens of non-cancerous renal cortex tissue (N) obtained from 68 patients with clear cell renal cell carcinomas (RCCs) in an initial cohort. As positive controls, two RCCs associated with Xp11.2 translocation were analyzed. After verification by reverse transcription (RT)-PCR and Sanger sequencing, 26 novel chimeric transcripts were identified in 17 (25%) of the 68 clear cell RCCs. Genomic breakpoints were determined in five of the chimeric transcripts. Quantitative RT-PCR analysis revealed that the mRNA expression levels for the MMACHC, PTER, EPC2, ATXN7, FHIT, KIFAP3, CPEB1, MINPP1, TEX264, FAM107A, UPF3A, CDC16, MCCC1, CPSF3, and ASAP2 genes, being partner genes involved in the chimeric transcripts in the initial cohort, were significantly reduced in 26 T samples relative to the corresponding 26 N samples in the second cohort. Moreover, the mRNA expression levels for the above partner genes in T samples were significantly correlated with tumor aggressiveness and poorer patient outcome, indicating that reduced expression of these genes may participate in malignant progression of RCCs. As is the case when their levels of expression are reduced, these partner genes also may not fully function when involved in chimeric transcripts. These data suggest that generation of chimeric transcripts may participate in renal carcinogenesis by inducing dysfunction of tumor-related genes.

AB - The aim of this study was to clarify the participation of expression of chimeric transcripts in renal carcinogenesis. Whole transcriptome analysis (RNA sequencing) and exploration of candidate chimeric transcripts using the deFuse program were performed on 68 specimens of cancerous tissue (T) and 11 specimens of non-cancerous renal cortex tissue (N) obtained from 68 patients with clear cell renal cell carcinomas (RCCs) in an initial cohort. As positive controls, two RCCs associated with Xp11.2 translocation were analyzed. After verification by reverse transcription (RT)-PCR and Sanger sequencing, 26 novel chimeric transcripts were identified in 17 (25%) of the 68 clear cell RCCs. Genomic breakpoints were determined in five of the chimeric transcripts. Quantitative RT-PCR analysis revealed that the mRNA expression levels for the MMACHC, PTER, EPC2, ATXN7, FHIT, KIFAP3, CPEB1, MINPP1, TEX264, FAM107A, UPF3A, CDC16, MCCC1, CPSF3, and ASAP2 genes, being partner genes involved in the chimeric transcripts in the initial cohort, were significantly reduced in 26 T samples relative to the corresponding 26 N samples in the second cohort. Moreover, the mRNA expression levels for the above partner genes in T samples were significantly correlated with tumor aggressiveness and poorer patient outcome, indicating that reduced expression of these genes may participate in malignant progression of RCCs. As is the case when their levels of expression are reduced, these partner genes also may not fully function when involved in chimeric transcripts. These data suggest that generation of chimeric transcripts may participate in renal carcinogenesis by inducing dysfunction of tumor-related genes.

UR - http://www.scopus.com/inward/record.url?scp=84907952394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907952394&partnerID=8YFLogxK

U2 - 10.1002/gcc.22211

DO - 10.1002/gcc.22211

M3 - Article

C2 - 25230976

AN - SCOPUS:84907952394

VL - 53

SP - 1018

EP - 1032

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 12

ER -